(19)
(11) EP 1 305 045 A1

(12)

(43) Date of publication:
02.05.2003 Bulletin 2003/18

(21) Application number: 01939050.9

(22) Date of filing: 16.05.2001
(51) International Patent Classification (IPC)7: A61K 39/395, C07K 16/32
(86) International application number:
PCT/US0115/677
(87) International publication number:
WO 0200/4021 (17.01.2002 Gazette 2002/03)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 12.07.2000 US 217706 P
31.01.2001 US 772938

(71) Applicant: Idec Pharmaceuticals Corporation
San Diego, CA 92121 (US)

(72) Inventors:
  • HANNA, Nabil
    Rancho Santa Fe, CA 92067 (US)
  • HARIHARAN, Kandasamy
    San Diego, CA 92129 (US)

(74) Representative: Daniels, Jeffrey Nicholas et al
Page White & Farrer54 Doughty Street
London WC1N 2LS
London WC1N 2LS (GB)

   


(54) TREATMENT OF B CELL MALIGNANCIES USING COMBINATION OF B CELL DEPLETING ANTIBODY AND IMMUNE MODULATING ANTIBODY RELATED APPLICATIONS